Global Endotoxin and Pyrogen Testing Market is expected to grow with the CAGR of 11.3% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.

Access Full Report @ https://www.databridgemarketresearch.com/reports/global-endotoxin-and-pyrogen-testing-market

Endotoxin and pyrogen testing market is a highly consolidated market, which includes specific number of key players as well as local players. The market has witnessed increased strategic developments owing to favourable market scenario.

The major players dealing in global endotoxin and pyrogen testing market are introducing strong range of product portfolio. This helped companies to maximize the sales with enhanced product portfolio. For instance, In October 2018, Lonza unveiled its latest PyroCell MAT System to detect various pyrogens sensitively and sustainably, without the need for laboratory animals. The product was launched with a full solution with optimized MAT reagents from Sanquin and media and accessories from Lonza. The company's introduction of this new product has boosted its credibility and market demand.

Pall Corporation (a subsidiary of Danaher), is dominating player in global endotoxin and pyrogen testing market. The other key players existing in the market includes Eurofins Scientific, Thermo Fisher Scientific Inc., Lonza, Charles River Laboratories, Merck KGaA, STERIS plc, SGS SA, Sartorius AG, bioMérieux SA, Ellab A/S, Wako USA (A subsidiary of FUJIFILM Wako Pure Chemical Corporation), ASSOCIATES OF CAPE COD, INC., WuXi AppTec, Microcoat Biotechnologie GmbH, Sanquin, Reading Scientific Services Ltd, nanoComposix, Zwisler Laboratorium GmbH and GenScript, among others.

Pall Corporation (A Subsidiary of Danaher)

Pall Corporation (a subsidiary of Danaher) is headquartered in New York, U.S. was founded in 1946. The company focuses on the high-tech filtration, separation and purification solutions to meet critical fluid management needs of a broad spectrum of life sciences and industrial sectors. The company offers wide range of product in various categories such as biotech, food and beverage, laboratory, medical, aerospace, chemicals & polymers, industrial manufacturing, microelectronics, oil & gas and power generation out of which biotech and laboratory is market focused category.      

• In December 2018, Pall Corporation (A Subsidiary of Danaher) established the Center of Excellence (CoE) for biotech integrated solutions in Shanghai, China. This new excellence center opened by the company, equipped with advanced equipment and platforms has increased the production capacity of the products leading to balance in meeting the demand of the people in the region.         

The company has presence in North America, South America, Europe, Asia-Pacific, and Middle East & Africa. The company has various subsidiaries that are Pall Australia (Australia), Pall Dreieich (Germany), Pall Corporation Filtration & Separations Ltd. (Thailand), Pall (Malaysia) Sdn Bhd (Malaysia) and Pall China - Beijing Office (China) among more.

Eurofins Scientific

Eurofins Scientific is headquartered in Val Flieuri, Luxembourg and was founded in year 1987. The company is engaged in food, environment, pharmaceutical and cosmetic products testing and in agroscience CRO services along with the expertise in testing and laboratory services for genomics, discovery pharmacology, and forensics, advanced material sciences and for supporting clinical studies. The company offers wide range of product in various categories such as agroscience services, agro testing, assurance, biopharma services, clinical diagnostics, consumer product testing, cosmetics & personal care, environment testing, food and feed testing, forensic services, genomic services, materials and engineering, reach services and Eurofins technologies out of which biopharma services is market focused category.    

• In March 2016, Eurofins Scientific acquired AMS Laboratories Pty Ltd., an Australia based independent supplier of analytical and cGMP Quality Control services for medical devices and biopharmaceutical products. This acquisition done by the company has strengthened the foothills of the company in biopharmaceutical products testing in Australia region.

The company has wide global presence across the world as North America, Europe, Asia-Pacific, South America, Middle East and Africa with its various subsidiaries such as Lancaster Laboratories Inc. (U.S.), Eurofins Biomnis (France), Eurofins Megalab (Spain), Eurofins Environmental Testing Australia Pty Ltd (Australia) and Eurofins Forensic Belgium bvba (Belgium) among more.

Lonza

Lonza is headquartered in Basel, Switzerland and was founded in 1897. The company is engaged in offering solutions for integrated healthcare solutions and in pharma, biotech & nutrition along with specialty ingredients. The company offers wide range of product in various categories such as pharma biotech & nutrition and specialty ingredients out of which pharma biotech & nutrition is market focused category.

• In October 2020, Lonza unveiled its latest PyroCell MAT System to detect various pyrogens sensitively and sustainably, without the need for laboratory animals. The product was launched with a full solution with optimized MAT reagents from Sanquin and media and accessories from Lonza. The company's introduction of this new product has boosted its credibility and market demand.

The company has wide global presence across North America, South America, Europe, Asia-Pacific, and Middle East & Africa. The company has various subsidiaries Arch Quimica, S.A. de C.V (Mexico), Lonza America Inc. (U.S.), Lonza Japan Ltd (Lonza Japan KabushikiKaisha) (Japan), Seed Fund Cycle-C3E (A), L.P (Canada) and Lonza Holding Singapore Pte Ltd (Singapore) among others.